Gene editing: beyond the hype
pharmaphorum
JANUARY 29, 2021
Since Macrae joined the company just four years ago, Sangamo has more than tripled its staff and raised $1.6 It has also built its own manufacturing site and launched partnerships with six big pharma companies. Zinc fingers are the most common control gene in the body,” Macrae explains. “We billion in funding.
Let's personalize your content